Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Etidronate disodium 400mg/5ml oral suspension
0606020C0AAADAD
|
Etidronate disodium | Etidronate disodium | Endocrine System | No data available |
|
Etodolac 200mg capsules
1001010E0AAAAAA
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | No data available |
|
Etomidate 20mg/10ml solution for injection ampoules
1501010C0AAAAAA
|
Etomidate | Etomidate | Anaesthesia | No data available |
|
Etopophos 100mg powder for solution for injection vials
0801040D0BDAAAG
|
Etopophos | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg capsules
0801040D0AAABAB
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg powder for solution for injection vials
0801040D0AAAGAG
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg/5ml solution for infusion vials
0801040D0AAADAD
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 200mg/10ml solution for infusion vials
0801040D0AAAEAE
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 500mg/25ml solution for infusion vials
0801040D0AAAFAF
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 50mg capsules
0801040D0AAAAAA
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etravirine 100mg tablets
0503010AFAAAAAA
|
Etravirine | Etravirine | Infections | No data available |
|
Etravirine 200mg tablets
0503010AFAAABAB
|
Etravirine | Etravirine | Infections | No data available |
|
Etravirine 25mg tablets
0503010AFAAACAC
|
Etravirine | Etravirine | Infections | No data available |
|
Etynodiol 500microgram tablets
0703021C0AAAAAA
|
Etynodiol diacetate | Etynodiol diacetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Eucardic 12.5mg tablets
020400080BBAAAB
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucardic 25mg tablets
020400080BBABAC
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucardic 3.125mg tablets
020400080BBACAE
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucardic 6.25mg tablets
020400080BBADAF
|
Eucardic | Carvedilol | Cardiovascular System | No data available |
|
Eucerin Acute 5% lip balm
190205500BCQFA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Eucerin Anti-Redness Calming Night cream
130201000BBLFA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eucerin Anti-Redness Neutralising Day fluid
130201000BBLGA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eucerin Dry Skin Relief bath therapy oil
190205500BCDSA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Eucerin Dry Skin Relief soothing spray
130201000BBJYA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Eucerin UreaRepair Plus Replenishing 5% body wash
1302010U0BGAKA0
|
Eucerin | Urea | Skin | No data available |
|
Eudemine 300mg/20ml solution for injection ampoules
0205010E0BBAAAA
|
Eudemine (Parenteral) | Diazoxide | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.